SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001759143-20-000003
Filing Date
2020-10-13
Accepted
2020-10-13 12:48:41
Documents
1
Effectiveness Date
2020-10-13
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8901
  Complete submission text file 0001759143-20-000003.txt   10058
Mailing Address TMCX - TEXAS MEDICAL CENTER ACCELERATOR 2450 HOLOCOMBE BLVD EAST, SUITE X HOUSTON TX 77021
Business Address TMCX - TEXAS MEDICAL CENTER ACCELERATOR 2450 HOLOCOMBE BLVD EAST, SUITE X HOUSTON TX 77021 713-503-7707
Stingray Therapeutics, Inc. (Filer) CIK: 0001759143 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-373125 | Film No.: 201235661